Related references
Note: Only part of the references are listed.Barriers to adult immunization
David R. Johnson et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons
Patricia R. Blank et al.
BMC PUBLIC HEALTH (2008)
Biology of immune responses to vaccines in elderly persons
Birgit Weinberger et al.
CLINICAL INFECTIOUS DISEASES (2008)
Influenza and respiratory syncytial virus in the elderly
Alex J. Elliot et al.
EXPERT REVIEW OF VACCINES (2008)
Clinical data on Fluarix®:: an inactivated split seasonal influenza vaccine
Hana M. El Sahly et al.
EXPERT REVIEW OF VACCINES (2008)
Pandemic H5N1 influenza vaccine development: an update
Hana M. El Sahlyt et al.
EXPERT REVIEW OF VACCINES (2008)
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
Jean-Francois Nicolas et al.
EXPERT REVIEW OF VACCINES (2008)
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults
Karin Levie et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
Kenneth M. Zangwill et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: A randomized controlled trial
David Holland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Non-traditional settings for influenza vaccination of adults - Costs and cost effectiveness
Lisa A. Prosser et al.
PHARMACOECONOMICS (2008)
Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program
Angelique G. S. C. Jansen et al.
VACCINE (2008)
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
Paul Henri Lambert et al.
VACCINE (2008)
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults
Isabel Leroux-Roels et al.
VACCINE (2008)
Vaccination of Macaques with adjuvanted formalin-inactivated influenza a virus (H5N1) vaccines: Protection against H5N1 challenge without disease enhancement
Caroline Ruat et al.
JOURNAL OF VIROLOGY (2008)
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Iris de Bruijn et al.
VACCINE (2007)
Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system
Philippe E. Laurent et al.
VACCINE (2007)
Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use
Sabine Arnoux et al.
VACCINE (2007)
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
Derek T. O'Hagan
EXPERT REVIEW OF VACCINES (2007)
Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines
Aurelie Laurent et al.
VACCINE (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients
Hasan Micozkadioglu et al.
RENAL FAILURE (2007)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip®
V Delore et al.
VACCINE (2006)
Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs
F. Hofmann et al.
INFECTION (2006)
Influenza vaccination in elderly people
L Simonsen et al.
LANCET (2005)
The macroepidemiology of influenza vaccination in 56 countries, 1997-2003
DS Fedson et al.
VACCINE (2005)
Clinical experience with inactivated, virosomal influenza vaccine
IA de Bruijn et al.
VACCINE (2005)
The unmet need in the elderly: Designing new influenza vaccines for older adults
JE McElhaney
VACCINE (2005)
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
C Nicolson et al.
VACCINE (2005)
Impact of influenza vaccination on seasonal mortality in the US elderly population
L Simonsen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prevention of influenza in the general population
JM Langley et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
KL Nichol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pharmacoeconomics of influenza vaccination for healthy working adults - Reviewing the available evidence
MJ Postma et al.
DRUGS (2002)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
VACCINE (2001)
Share Paper
